Tundra Space

Tundra Space

Book DemoDirectoryLog InSign Up

Clinical Research Directory

Browse clinical research sites, groups, and studies.

SitesGroupsStudies
Back to Studies
ACTIVE NOT RECRUITING
NCT02065011
PHASE2

A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B

Sponsor: Sanofi

View on ClinicalTrials.gov

Summary

Primary Objective: To evaluate the long-term safety and tolerability of SAR421869 in patients with Usher syndrome Type 1B Secondary Objective: To assess long-term safety and biological activity of SAR421869

Official title: An Open-label Study to Determine the Long-term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

9

Start Date

2013-09-12

Completion Date

2031-06-13

Last Updated

2026-01-13

Healthy Volunteers

No

Conditions

Usher's Syndrome

Interventions

DRUG

Blood draw for the laboratory assessment

Locations (2)

Oregon Health and Science University Site Number : 840001

Portland, Oregon, United States

Investigational Site Number : 250001

Paris, France